Real-time enrollment status for this multiple sclerosis clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 3:26 AM UTC
| NCT Number | NCT06220669 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Multiple Sclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | April 7, 2026 (1 week ago) |
As of April 17, 2026: Clinical trial NCT06220669 is currently active_not_recruiting participants. This clinical trial study for multiple sclerosis is not currently accepting new participants at 16 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06220669 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06220669 was last updated 1 week ago (April 7, 2026). HelloStudys verifies this status automatically.